/ Unknown statusPhase 2/3 An Open-Label, Multicentre, Long-Term Follow-Up Study to Investigate the Safety and Durability of Response Following Dosing of a Novel Adeno-Associated Viral Vector (FLT180a) in Patients with Haemophilia B
100 Clinical Results associated with Freeline Therapeutics (Ireland) Ltd.
0 Patents (Medical) associated with Freeline Therapeutics (Ireland) Ltd.
100 Deals associated with Freeline Therapeutics (Ireland) Ltd.
100 Translational Medicine associated with Freeline Therapeutics (Ireland) Ltd.